Home/ Stocks/ INDV

Indivior Pharmaceuticals, Inc. Common Stock

INDV XNAS

$38.82 +0.15 (+0.39%) ▲ 15-min delayed

Open

$38.83

High

$38.91

Low

$38.08

Volume

1.69M

Market Cap

$4.56B

About Indivior Pharmaceuticals, Inc. Common Stock

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 838 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$343.00M	$122.00M	$1.02
FY 2025	$1.24B	$210.00M	$1.68
Q3 2025	$314.00M	$42.00M	$0.34
Q2 2025	$302.00M	$18.00M	$0.15

Related Market News

No specific coverage for INDV yet. Check out our latest market news or earnings calendar.

Get INDV Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Indivior Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.